| Literature DB >> 879836 |
Abstract
'Universal strength' BCG vaccine was given to 219 neonates and 2 months later 159 infants were Mantoux-tested with 5 Tu PPD-S and their BCG scars measured. The results showed a satisfactory conversion rate of over 90%. Though 30% of the lesions discharged, this only lasted for a few days and the vaccine was well tolerated and acceptable for use in neonates.Entities:
Mesh：
Substances：
Year: 1977 PMID： 879836 PMCID： PMC1544706 DOI： 10.1136/adc.52.6.503
Source DB: PubMed Journal: Arch Dis Child ISSN： 0003-9888 Impact factor: 3.791